<DOC>
	<DOCNO>NCT00762424</DOCNO>
	<brief_summary>Tamsulosin ( Flowmax ) approve FDA treatment enlarge prostate . Several study regard use Tamsulosin treatment low kidney stone carry non-Emergency Department setting . This study compare Tamsulosin 0.4 mg placebo regard rate time stone passing also look amount pain . The purpose study compare usefulness Tamsulosin versus placebo time stone passage pain relief Emergency Department patient kidney stone .</brief_summary>
	<brief_title>Effect Tamsulosin Stone Expulsion Pain Resolution ED Patients With Ureterolithiasis</brief_title>
	<detailed_description />
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>18 y.o . old diagnose kidney stone less equal 10 mm determine CT scan physician make decision discharge home must able take study medication 10 day strain urine must able keep record pain medication take complete pain scale rating patient currently take : Tamsulosin ( Flowmax ) , calcium channel blocker , beta blocker , alpha blocker , Sildenaphil ( Viagara ) , Tadalaphil ( Cilias ) , Warfarin ( Coumadin , Jantoven ) , Cimetidine ( Tagamet , Tagamet HB ) patient clinical laboratory sign : urinary tract infection , multiple kidney stone , diabetes , kidney failure , hypotension , pregnancy , fever patient know hypersensitivity Tamsulosin patient history cataract surgery inability patient perform visual pain scale allergy intolerance acetaminophen/oxycodone patient unable understand inform consent prisoner</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Kidney stone</keyword>
	<keyword>Ureterolithiasis</keyword>
	<keyword>Tamsulosin</keyword>
	<keyword>Flowmax</keyword>
	<keyword>Emergency Department</keyword>
</DOC>